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Obesity is a multifactorial body weight abnormality resulting from 
genetic and environmental interactions. Of the body mass index 
(BMI) variation among obese individuals of different populations 
and within the same family, 40 - 70% are estimated to be inherited, 
and 30% are attributed to cultural and socio-economic factors.1,2 
More than 100 genes have been implicated in the heterogeneity 
of body weight, among which are genes that encode proteins or 
peptides of the central nervous system that affect conscious and 
unconscious aspects of energy intake and expenditure. Melanocortin 
receptors, particularly the melanocortin 4 receptor gene (MC4R), 
play a major role in the development of both monogenic and 
polygenic obesity.3,4 Mutations in MC4R are the most common cause 
of early onset obesity, accounting for up to 6%, particularly in white 
populations.3 Furthermore, more than 50 additional MC4R single 
nucleotide polymorphisms have been reported in obese and control 
individuals, with different effects depending on the population 
and family studied.4 Recently, obesity-related mutations (A293T, 
I335S, X361S, I183, A70T and M134I) have been identified in the 
melanocortin-3 receptor gene (MC3R) – another energy-regulating 
melanocortin receptor.5,6 Similar to MC4R polymorphisms, common 
variants in MC3R show significant frequency variation among 
different populations, accompanied by controversial effects on 
obesity phenotypes.5,7
Epidemiological studies8 show that overweight and obesity 
prevalence rates in South African pupils are fast approaching those 
observed in developed countries, but the contribution of genetic 
factors is under-investigated. We analysed MC4R and MC3R for 
sequence variants that may contribute to the development of obesity 
in pupils from South Africa.  
Methods
We aimed at determining the prevalence of metabolic syndrome and 
obesity in South African school pupils residing in Cape Town.9 A 
total of 431 (227 obese-overweight, and 204 normal) individuals of 
11 - 16 years of age were selected, comprising black and coloured 
South Africans. The following measurements were performed on 
all pupils: anthropometric measurements (body weight and height, 
waist and hip circumference, waist-hip ratio, skinfold thickness etc.). 
Skinfold thickness was measured at 3 different body sites (subscapular, 
supra-ileac and upper arm); body mass index (BMI) was calculated as 
weight per square meter (kg/m2); and 3 readings were taken for blood 
pressure and waist and hip circumferences. Subjects were classified 
according to their weight status as obese, overweight and normal 
using the International Obesity Task Force criteria.10 Blood glucose, 
lipid levels and blood pressure have previously been described.9
Mutation analysis and genotyping
Genomic DNA was extracted from either whole blood collected 
in vacutainer ethylenediamine tetra-acetic acid (EDTA) tubes 
or capillary blood collected onto Whatman FTA Cards (Merck 
Laboratories, UK). Subjects were screened for MCR3 and MCR4 
coding sequence variants by amplifying the coding regions and 
splice junctions11,12 and subsequent single strand conformation 
polymorphism (SSCP) analysis. Amplicons with aberrant band 
patterns were further analysed by automated sequencing using ABI Corresponding author: T Matsha (matshat@cput.ac.za) 
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Background. Human and animal studies support the role of MC4R 
and MC3R in human obesity, but limited data are available on the 
genetic contribution to obesity in South African populations. 
Objective. To screen obese-overweight South African pupils 
for MC3R and MC4R polymorphisms that may play a role in the 
development of obesity.
Design. A cross-sectional study screened 227 obese-overweight 
(115 black and 112 coloured) and 204 normal weight (94 black, 
110 coloured) school pupils for the presence of MC4R and MC3R 
polymorphisms using a single strand conformation polymorphism, 
subsequent sequencing, and allele specific restriction enzyme 
analysis.
Results. Two polymorphisms were detected in the MC3R (T6K 
and V81I) but none in MC4R. After adjusting for age, gender 
and case-control status, the frequency distributions of T6K and 
V81I genotype and allele varied significantly between the ethnic 
groups. The frequency of the V81I A allele was significantly lower 
in coloured overweight-obesity than normal pupils. In coloured 
pupils, both polymorphisms were associated with obesity indices 
and total cholesterol.  The T6K A allele was also associated with 
lower blood pressure. Likewise, different T6K-V81I haplotypes 
demonstrated negative associations with obesity indices and blood 
pressure.
Conclusion. We demonstrated that the MC3R polymorphisms 
have a protective effect on metabolic traits; however, further 
analysis is required to confirm whether this translates to a lower 
incidence of metabolic syndrome in coloured populations.
S Afr Med J 2011;101:417-420. 
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3730. Subjects were genotyped for the presence of identified sequence 
variants using the allele-specific restriction enzyme analysis. The C 
allele of the K6T variant abolished the Mae III restriction enzyme 
recognition site, while the G allele of the V81I polymorphism created 
a second restriction recognition site for the BseD 1 enzyme.
Statistical analysis
Our sample size calculation was guided by the following factor: If 
the ‘risk’ allele frequency in the general population (controls) is 40%, 
then 227 cases and 204 controls have 80% power to detect, at a 5% 
significance level, a ‘risk’ allele frequency of 52% in cases.
Logistic regression assessed case-control association with genotype 
and race in joint models.  Allelic distributions differed highly 
significantly between ethnic groups. The differences were such that 
adjusting trait-gene association analyses for ethnicity would not be 
valid. All analyses were therefore stratified by ethnicity. We tested 
association between quantitative traits and genotypes, alleles (additive) 
and haplotypes for the two polymorphisms. Triglycerides and diastolic 
and systolic blood pressure were log-transformed prior to analysis, 
because of skewed distributions. Effect estimates were obtained from 
linear models. Genotype-association (2 degrees of freedom) was tested 
by coding genotype as a categorical factor and allelic association (1 
degree of freedom) with a numerical variable, counting the number 
of derived (A) alleles. We inferred haplotypes from the genotypes of 
the two variants and compared frequencies between obese and control 
learners. Models were adjusted for age and gender, and replicated 
measurements were controlled for as random effects.
Data were analysed using the programming language R (www.r-
project.org) and specifically packages DGC-genetics (LD, Hardy-
Weinberg, genotype and allelic association) and haplo.stats (inferred 
haplotype association).
Ethical approval was obtained from the Research Ethics Committee 
of the University of Stellenbosch (Project number: N07/ 07/ 160) and 
from the Faculty of Health and Wellness Science Ethics Committee, 
Cape Peninsula University of Technology (Project Reference number: 
CPUT/ HAS-REC 0016). Written consent was obtained from the 
parents or guardians of pupils, and oral assent from pupils was 
obtained on the sampling day.
Results
Table I summarises physical characteristics and metabolic outcomes 
according to ethnicity. By selection, obesity indices were significantly 
higher in obese-overweight pupils. Analyses were adjusted for age 
and gender. The fasting blood glucose (FBG) was independently 
significantly higher in coloured than in black pupils (p=0.0001) and 
obese-overweight than in normal-weight pupils (p=0.0307). The 
HDL-C was higher in normal weight than obese-overweight pupils 
(p=0.0008) and in black compared with coloured pupils (p<0.0001). 
Triglyceride levels were similar in both racial groups, but significantly 
higher in obese-overweight pupils (p=0.0038).
No sequence variants were identified on MC4R, while two 
common sequence variants (T6K and V81I) were identified in the 
MC3R coding region. The two coding variants were in strong linkage 
disequilibrium in all groups, ranging from D’= 0.7437 in coloured 
normal-weight pupils to D’=0.9264 in the black obese pupils. 
The frequency distributions (both genotype and allele) differed 
significantly between the ethnic groups, after adjusting for case-
control status. The differences were such that potential effects would 
be cancelled out if the genotype association test were adjusted for 
ethnicity. Therefore all subsequent analyses were stratified according 
to ethnicity. The frequency of the V81I A allele was significantly 
different between coloured overweight-obesity and normal weight 
pupils (respectively 28% and 40%, p=0.0144) while that of the T6K A 
allele was only significantly different between the two ethnic groups. 
The A allele frequency was significantly higher in black pupils (p 
<0.0001) (Table II). After adjusting for gender and age, both T6K 
Table I. Physical characteristics and metabolic outcomes of obese-overweight and normal black and coloured South African learners
Obese-overweight Normal weight p-value
Black Coloured Black Coloured Obesity Race
N 115 112 94 110
Age (years) 13.2±2.0 13.4±2.0 13.3±2.0 13.6±2.1 0.3502 0.2074
Gender, male (%) 21 (25) 26 (31) 16 (19) 20 (24) 0.4208 0.4048
Weight (kg) 62.7±12.5 65.4±13.9 46.3±8.5 45±9.6 <0.0001 0.4580
Height (cm) 153.3±8.1 156.3±8.7 153.5±9.3 153.3±10.8 0.0983 0.1046
BMI (kg/m2) 26.5±3.6 26.6±4.1 19.5±2.1 19±2.5 <0.0001 0.5021
Mid-upperarm (cm) 27.5±3.4 27.7±3.2 22.7±2.5 22.1±2.3 <0.0001 0.4769
Waist (cm) 79.4±8.8 80.4±10.1 66.4±6.6 64.9±6.7 <0.0001 0.8103
Hip (cm) 99.1±9.5 100.9±10.1 84.7±8.3 84.6±9.1 <0.0001 0.2965
FBG (mmol/l) 3.9±0.8 4.2±0.8 3.8±0.8 4.1±0.7 0.0307 0.0001
TC (mmol/l) 3.8±1 3.7±0.8 3.7±0.8 3.7±0.8 0.5086 0.5559
TG (mmol/l)* 0.73 (0.57, 0.95) 0.65 (0.57, 0.99) 0.57 (0.57, 0.79) 0.57 (0.57, 0.80) 0.0038 0.2420
HDL-C (mmol/l) 1.1±0.4 0.9±0.3 1.2±0.4 1.1±0.4 <0.0001 0.0008
SBP (mmHg)* 114 (104, 123) 111 (105, 117) 103 (97, 115) 104 (95, 116) <0.0001 0.5052
DBP (mmHg)* 69 (63, 78) 69 (64, 73) 64 (59, 71) 66 (59, 72) <0.0001 0.9976
Summary statistics: mean±SD unless indicated otherwise.
p-values are for joint model, so each is adjusted for the other.
*Triglycerides and diastolic and systolic blood pressures were summarised as median (interquartile range) and were log-transformed to symmetry for tests.
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and V81I showed associations with obesity indices (body weight, 
BMI, hip and mid-upper arm) and total cholesterol, while only the 
T6K was associated with blood pressure in coloured pupils. In the 
latter pupils, the estimated effect of the T6K A allele was a decrease 
of 0.814 cm in mid-upper arm circumference (p=0.0268), 2.873 cm 
in hip circumference (p=0.0099), 3.225 kg in weight (p=0.0216) 
and a corresponding 0.959 kg/m2 in BMI (p=0.0476). In addition, 
the T6K A allele reduced the systolic and diastolic blood pressures, 
respectively by 2.498 (p=0.0467) and 2.087 mmHg (p=0.0213). In 
coloured pupils, the V81I A allele decreased total cholesterol by 0.162 
mmo/l (p=0.0307), waist circumference by 2.141 cm (p=0.0362), hip 
circumference by 2.852 cm (p=0.0071), mid-upper arm circumference 
0.878 cm (p=0.0119), weight 3.575 kg (p=0.0074) and BMI 1.168 kg/
m2 (p=0.0110). 
There was no significant variation in the distribution of the T6K-
V81I haplotype in the black group (global p=0.1089) between obese-
overweight and normal weight pupils. Furthermore, no significant 
association between the T6K-V81I haplotype and physical or 
metabolic traits were observed in black pupils. However, the C-A was 
higher in normal weight (5% v. 2%), and A-A haplotype was higher 
in obese-overweight (52% versus 44%), respectively (p=0.0688) and 
0.0749, while the C-G haplotype was most common in the normal 
weight (48%) rather than in obese-overweight (43%). In coloured 
pupils, the haplotype distributions differed significantly between 
obese-overweight and normal pupils (global p=0.0185); C-G was 
more prevalent in obese-overweight coloured pupils (69% v. 55%, 
p=0.0063) whereas C-A was more frequent in normal weight pupils 
(8% v. 2%, p=0.0142). In coloured pupils, after adjusting for age and 
gender, the C-A haplotype had 2.4 kg/m2 less BMI than the C-G, 
while the A-A haplotype increased weight by 3.3 kg less. Systolic 
and diastolic blood pressures were decreased by 10 and 7.5 mmHg 
respectively in A-G haplotype compared with the C-G haplotype in 
coloured pupils.
Discussion
Melanocortin 4 and 3 receptors are expressed in neurons of specific 
areas of the brain that regulate appetite and basal metabolic activity. 
Melanocortin receptors are part of the leptin-melanocortin pathway 
that plays a role in glucose homeostasis, insulin secretion, regulation 
of food intake, and energy balance. Neuropeptides in this pathway 
regulate food intake and energy balance by binding to melanocortin 
receptors, particularly MC4R, and to a lesser extent MC3R. Human 
and animal studies support the role of MC4R in human obesity,3,13 
while MC3R variants have recently been implicated as pathogenic 
mutations that may cause dominantly inherited obesity.5,6 We 
analysed MC4R and MC3R for sequence variants that may contribute 
to polygenic obesity in two South African ethnic groups, namely 
coloured and black populations. Sequence analysis of MC3R in 
our study groups detected 2 common polymorphisms that showed 
variability in the distribution pattern between these groups.
The minor A allele frequency of both polymorphisms were higher 
in black pupils than in coloured, and almost equally distributed in 
the black population independent of  obesity status. In the coloured 
group, the minor A allele of both polymorphisms in this study had a 
similar frequency ranging from 28% to 40% independent of obesity 
status. Compared with American whites,14,15 the homozygosity of 
these variants in coloured children was not as low. A prevalence 
of 15.8% of the T6K and V81I MCR3 homozygote minor alleles 
in African-Americans compared with 1.7% in whites has been 
reported.14 The variants were associated with several metabolic 
traits in the coloured group. This association is further reflected in 
the inferred haplotype analysis. Both variants were associated with 
obesity indices and total cholesterol, but only T6K was associated 
with blood pressure in coloured pupils. In the black pupils, T6K was 
associated with triglyceride only.
Likewise, T6K-V81I haplotype analysis demonstrated a negative 
association of A-A and C-A haplotypes, compared with the C-G 
Table II. The frequency distribution of T6K and V81I between obese-overweight and normal weight learners in the black and 
coloured groups
       Obese-overweight        Normal weight
              (N=227)             (N=204) p-value
Black Coloured Black Coloured Black Coloured Race
f (N) f (N) f (N) f (N)
T6K
typed 115 112 94 110
C 0.45 (104) 0.71 (159) 0.53 (99) 0.62 (137)
A 0.55 (126) 0.29 (65) 0.47 (89) 0.38 (83) 0.1055 0.0589 <0.0001
C/C 0.18 (21) 0.53 (59) 0.23 (22) 0.39 (43)
C/A 0.54 (62) 0.37 (41) 0.59 (55) 0.46 (51)
A/A 0.28 (32) 0.11 (12) 0.18 (17) 0.15 (16) 0.2237 0.1246 <0.0001
V81I
typed 115 112 94 110
G 0.46 (106) 0.72 (162) 0.51 (96) 0.6 (133)
A 0.54 (124) 0.28 (62) 0.49 (92) 0.4 (87) 0.2873 0.0144 <0.0001
G/G 0.19 (22) 0.54 (61) 0.23 (22) 0.42 (46)
G/A 0.54 (62) 0.36 (40) 0.55 (52) 0.37 (41)
A/A 0.27 (31) 0.1 (11) 0.21 (20) 0.21 (23) 0.561 0.0401 <0.0001
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haplotype with indices of obesity, while the A-G was negatively 
correlated with blood pressure compared with the C-G haplotype 
in coloured pupils, suggesting a possible protection from obesity 
and hypertension. The effect posed by the C-A haplotype should, 
however, be analysed with caution and investigated further as it was 
observed in only 2% of obese and 5% of normal pupils. Although the 
minor alleles of both T6K and V81I were more prevalent in black 
pupils than in coloured, neither allele nor haplotype association 
tests demonstrated correlation with obesity or other metabolic 
parameters in the former ethnic group. The A-A haplotype was 
most common (52%) in obese and overweight pupils whereas the 
C-G haplotype was the most common (48%) in normal weight black 
pupils. Similarly, an association between these polymorphisms and 
body weight in African-American women was not demonstrated.16 
Our results contrast with others that demonstrated an association 
between double homozygosity of these variants and high body 
weight, with minor allele carriers having greater body fat mass than 
those carrying the major alleles.5,17 Furthermore, MCR3 knock-out 
mice had increased fat mass and reduced lean mass, but hyperphagia, 
while heterozygotes had normal body composition.17
The association between the T6K-V81I and blood pressure (A-G 
having highly significantly lowered blood pressure than C-G, systolic 
10 mmHg, diastolic 7.5 mmHg) in coloured pupils further supports the 
dual role of MC3R in weight and blood pressure regulation.18 Human 
and animal studies support the role of MC3R in the development of 
obesity, but only animal models demonstrated its contribution in 
blood pressure regulation. Mice lacking MC3R had elevated levels 
of gamma melanocortin-stimulating hormone (γ-MSH) on both 
low- and high-salt diet, but developed hypertension on the high-salt 
diet,19 which suggests that the role of MC3R in blood pressure may 
only be apparent in the presence of a high salt concentration. MC3R 
may also play a role in regulation of blood pressure in humans, 
as epidemiological and functional studies have demonstrated the 
causative role of obesity in hypertension.20, 21
The MC4R (another melanocortin receptor) has also been 
implicated in blood pressure regulation. Animal and human studies 
showed that the defective MC4R confers a relative protective role on 
the expected increase of blood pressure in obese subjects.22,23 Intra-
cerebroventricular injection of γ-MSH elevated blood pressure and 
heart rate in wild-type mice but not in obese mice lacking Mc4r.22 
Obesity increases blood pressure, but a study23 showed that humans 
with MC4R-deficiency had lower blood pressure than the control 
group. Blood pressure of control subjects was similar to those of 
overweight and obese subjects without MC4R defects, suggesting that 
MC4R-deficient subjects were relatively protected from the expected 
relationship between overweight and raised blood pressure.  In our 
study, no sequence variants were identified in the MC4R, which is 
not surprising owing to rarity of polymorphisms implicated in mild 
obesity in this gene.4 Similarly to our findings, others also failed to 
detect sequence variants in MC4R.24 According to Jacobson et al., 
MC4R mutations are likely to occur in populations enriched with 
severe or early-onset obesity, and therefore are an uncommon cause 
of obesity in the general population. 24
Blood pressure, central obesity and elevated lipid profile are used 
to assess metabolic syndrome, which is a multiplex risk factor for 
cardiovascular diseases and type 2 diabetes. Individuals with lower 
waist circumference and blood pressure have a lower risk of developing 
cardiovascular diseases than those with higher values. Although the 
MC3R variants show a negative effect in blood pressure and weight 
gain among coloured pupils, the prevalence of metabolic syndrome 
among black and coloured pupils was not significantly different.9 
These findings may therefore be a reflection of gene-gene interaction 
and/or environmental factors rather than a measured risk of metabolic 
syndrome and/or cardiovascular diseases in these racial groups.
A limitation of this study was the use of the SSCP method to 
detect possible sequence variants, which might have contributed to 
the detection rate. This technique has been reported to detect up to 
98% (addition of 15% urea in both 8% and 10% polyacrylamide gels 
increases the detection limit from 90 to 98%) of nucleotide changes.25 
SSCP is also subject to human error regarding interpretation of 
mobility shifts; and other sequence variants that could have been 
detected by ABI sequencing might have been missed.
Conclusion
Our results support the role of MC3R variants in weight regulation, 
with larger effects in the coloured population, in whom T6K and V81I 
polymorphisms also exact different metabolic effects, supporting the 
dual role of MC3R in regulating body weight and blood pressure. 
Although our results demonstrate that the MC3R polymorphisms 
have a protective effect on these metabolic traits, further study is 
required to confirm whether this translates into a lower incidence of 
metabolic syndrome in coloured populations.
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